AJOG,
#SMFM17 Late-breaking: Eval of the safety, efficacy of recombinant antithrombin vs placebo in preterm... #SMFM17 Late-breaking…
LB02: Randomized double-blind placebo controlled evaluation of the safety and efficacy of recombinant Antithrombin versus placebo in preterm preeclampsia
Overview of attention for article published in American Journal of Obstetrics & Gynecology, January 2017
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
Good Attention Score compared to outputs of the same age and source (72nd percentile)
Mentioned by
- news
- 1 news outlet
- 2 X users
- patent
- 1 patent
- 1 Facebook page
- googleplus
- 1 Google+ user
Readers on
- mendeley
- 8 Mendeley